Skip to main content

Table 4 The changes in weight and clinical laboratory tests after 6 weeks in the studied groups

From: Adding L-carnitine to antagonist ovarian stimulation doesn’t improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: a double-blind randomized clinical trial

Variable

Baseline

Puncture day

Changes

p-value*

L-carnitine group

Weight (kg)

70.0 (12.0)

67.3 (9.6)

−2.65

< 0.001

FBS (mg/dL)

94.1 (12.0)

90.2 (6.7)

−3.95

0.021

Fasting Insulin (uIU/mL)

11.5 (5.3)

10.0 (4.8)

−1.46

0.004

Cholesterol (mg/dL)

161.1 (38.7)

142.7 (32.9)

−18.3

< 0.001

Triglyceride (mg/dL)

141.4 (50.8)

117.70 (43.9)

−24.4

< 0.001

LDL (mg/dL)

98.6 (32.6)

82.0 (28.1)

−16.6

< 0.001

HDL (mg/dL)

43.5 (14.0)

46.8 (13.5)

3.3

< 0.001

Control group

Weight (kg)

70.6(10.2)

70.3 (10.5)

−0.35

0.56

FBS (mg/dL)

92.4 (8.9)

92.3 (9.0)

0.10

0.89

Fasting insulin (uIU/mL)

10.1 (5.6)

10.4 (4.7)

0.39

0.26

Cholesterol (mg/dL)

162.1 (35.4)

161.9 (31.7)

−0.18

0.94

Triglyceride (mg/dL)

120.7 (52.1)

125.1 (46.9)

−4.43

0.25

LDL (mg/dL)

96.3 (27.1)

95.4 (28.9)

−0.83

0.73

HDL (mg/dL)

46.7 (12.4)

47.2 (11.5)

0.46

0.52

  1. Values are presented as the Mean ± Standard deviation (SD). * Obtained by paired t test. Statistically significant level was 0.05